Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Clorazepate therapy for intractable epilepsy.

T Fujii¹, T Okuno, T Go

¹Department of Pediatrics, Faculty of Medicine, Kyoto University, Japan.

Brain & Development

|January 1, 1987

Summary

Clorazepate dipotassium showed potential as a secondary treatment for intractable epilepsy, improving seizure frequency in some patients. Drowsiness was the primary side effect, often resolving within a week.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The third cell.

Journal of clinical pathology·2006

Same author

Non-invasive estimation of arterial blood pH using exhaled CO/CO2 analyser, microwave radar and infrared thermography for patients after massive haemorrhage.

Journal of medical engineering & technology·2006

Same author

Effect of betaxolol hydrochloride on heart rate variability indices during exercise stress testing in patients with hypertension.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2005

Same author

Effect of antiarrhythmic agents on heart rate variability indices after myocardial infarction: comparative experimental study of aprindine and procainamide.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2005

Same author

A novel apparatus for non-contact measurement of heart rate variability: a system to prevent secondary exposure of medical personnel to toxic materials under biochemical hazard conditions, in monitoring sepsis or in predicting multiple organ dysfunction syndrome.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2005

Same author

Dialysis-related amyloidosis of the temporomandibular joint.

International journal of oral and maxillofacial surgery·2005

Area of Science:

Neurology
Pharmacology

Background:

Epilepsy is a chronic neurological disorder characterized by recurrent seizures.
Intractable epilepsy, defined as seizures refractory to conventional anticonvulsants, presents significant treatment challenges.

Purpose of the Study:

To evaluate the efficacy and tolerability of clorazepate dipotassium as an add-on therapy for patients with intractable epilepsy.

Main Methods:

A cohort of 31 epileptic patients with refractory seizures received clorazepate dipotassium as an adjunct treatment.
Seizure frequency and adverse effects were monitored throughout the study period.

Main Results:

Twelve patients (38.7%) experienced improved seizure frequency, with three achieving a seizure-free state.

Related Experiment Videos

Patients with partial epilepsy showed a better response compared to those with secondary generalized epilepsy.

Generalized tonic-clonic and simple partial seizures tended to respond better than other seizure types.

Drowsiness was the most common adverse effect, reported by 14 patients, leading to withdrawal in 6, but often transient.

Conclusions:

Clorazepate dipotassium may serve as an effective secondary anticonvulsant for managing intractable epilepsy.
While drowsiness is a notable side effect, it is often manageable and does not preclude its therapeutic use.